Practical Geriatrics ›› 2024, Vol. 38 ›› Issue (8): 802-807.doi: 10.3969/j.issn.1003-9198.2024.08.011
Previous Articles Next Articles
WANG Xinping, XIE Baimei, WEI Guo, YE Xiaoli, ZHAO Yayun, TAN Xiaotian
Received:
2023-10-15
Online:
2024-08-20
Published:
2024-08-26
Contact:
TAN Xiaotian, Email: tanxiaotian451@126.com
CLC Number:
WANG Xinping, XIE Baimei, WEI Guo, YE Xiaoli, ZHAO Yayun, TAN Xiaotian. Expression levels and clinical significance of serum S100A9 and sCD163 in elderly patients with idiopathic interstitial pneumonia[J]. Practical Geriatrics, 2024, 38(8): 802-807.
[1] TODD N W, ATAMAS S P, HINES S E, et al. Demystifying idiopathic interstitial pneumonia: time for more etiology-focused nomenclature in interstitial lung disease[J]. Expert Rev Respir Med, 2022,16(2):235-245. [2] GUARNERA A, SANTINI E, PODDA P. Idiopathic interstitial pneumonias and COVID-19 pneumonia: review of the main radiological features and differential diagnosis[J]. Tomography, 2021,7(3):397-411. [3] MELLOR L F, GAGO-LOPEZ N, BAKIRI L, et al. Keratinocyte-derived S100A9 modulates neutrophil infiltration and affects psoriasis-like skin and joint disease[J]. Ann Rheum Dis, 2022, 81(10):1400-1408. [4] ARAKI K, KINOSHITA R, TOMONOBU N, et al. The heterodimer S100A8/A9 is a potent therapeutic target for idiopathic pulmonary fibrosis[J]. J Mol Med: Berl, 2021, 99(1):131-145. [5] BHATTACHARYA M. Insights from transcriptomics: CD163+ profibrotic lung macrophages in COVID-19[J]. Am J Respir Cell Mol Biol, 2022, 67(5):520-527. [6] YAMASHITA M, UTSUMI Y, NAGASHIMA H, et al. S100A9/CD163 expression profiles in classical monocytes as biomarkers to discriminate idiopathic pulmonary fibrosis from idiopathic nonspecific interstitial pneumonia[J]. Sci Rep, 2021, 11(1):12135-12141. [7] TRAVIS W D, COSTABEL U, HANSELL D M, et al. An official American Thoracic Society/European Respiratory Society statement:update of the international multidisciplinary classification of the idiopathic interstitial pneumonias[J]. Am J Respir Crit Care Med, 2013,188(6):733-748. [8] SAMARELLI A V, TONELLI R, MARCHION A, et al. Fibrotic idiopathic interstitial lung disease: the molecular and cellular key players[J]. Int J Mol Sci, 2021,22(16):8952-8966. [9] 李莉红, 白璐, 王鹏. 急性加重期特发性间质性肺炎患者血清多配体蛋白聚糖4水平变化及其与近期预后的关系研究[J]. 实用心脑肺血管病杂志, 2018,26(12):49-53. [10] 曾显荣, 弋春燕, 刘庆玲, 等. 寻常型间质性肺炎与非特异性间质性肺炎的临床特点及HRCT表现对比分析[J]. 中国CT和MRI杂志, 2022,20(4):39-42. [11] MONTEIRO C, MIARKA L, PEREA-GARC M, et al. Stratification of radiosensitive brain metastases based on an actionable S100A9/RAGE resistance mechanism[J]. Nat Med, 2022, 28(4):752-765. [12] SPRENKELER E G G, ZANDSTRA J, VAN K N D, et al. S100A8/A9 is a marker for the release of neutrophil extracellular traps and induces neutrophil activation[J]. Cells, 2022, 11(2):236-242. [13] GARCIA V, PERERA Y R, CHAZIN W J. A structural perspective on calprotectin as a ligand of receptors mediating inflammation and potential drug target[J]. Biomolecules, 2022, 12(4):519-525. [14] KIM R Y, SUNKARA K P, BRACKE K R, et al. A microRNA-21-mediated SATB1/S100A9/NF-κB axis promotes chronic obstructive pulmonary disease pathogenesis[J]. Sci Transl Med, 2021, 13(621): 7223-7230. [15] ELEFTHERIADIS T, PISSAS G, CRESPO M, et al. The effect of anti-HLA class I antibodies on the immunological properties of human glomerular endothelial cells and their modification by mTOR inhibition or GCN2 kinase activation[J]. Mol Med Rep, 2021,23(5):355-368. [16] OLALOYE O O, L P, TOOTHAKER J M, et al. CD16+CD163+ monocytes traffic to sites of inflammation during necrotizing enterocolitis in premature infants[J]. J Exp Med, 2021, 218(9):2020-2027. [17] CUTOLO M, CAMPITIELLO R, GOTELLI E, et al. The role of M1/M2 macrophage polarization in rheumatoid arthritis synovitis[J]. Front Immunol, 2022, 19(13):8672-8680. [18] LIU B, LI R, ZHANG J, et al. MicroRNA-708-3p as a potential therapeutic target via the ADAM17-GATA/STAT3 axis in idiopathic pulmonary fibrosis[J]. Exp Mol Med, 2018, 50(3):465-473. [19] CUTOLO M, CAMPITIELLO R, GOTELLI E, et al. The role of M1/M2 macrophage polarization in rheumatoid arthritis synovitis[J]. Front Immunol, 2022, 19(13):8672-8680. [20] YE Q, DALAVANGA Y, POULAKIS N, et al. Decreased expression of haem oxygenase-1 by alveolar macrophages in idiopathic pulmonary fibrosis[J]. Eur Respir J, 2008, 31(5):1030-1036. [21] YAMASHITA M, SAITO R, YASUHIRA S,et al. Distinct profiles of CD163-positive macrophages in idiopathic interstitial pneumonias[J]. J Immunol Res, 2018, 20(8):1436-1446. [22] SAMARELLI A V, TONELLI R, MARCHIONI A, et al. Fibrotic idiopathic interstitial lung disease: the molecular and cellular key players[J]. Int J Mol Sci, 2021, 22(16):8952-8959. [23] NOUNO T, OKAMOTO M, OHNISHI K, et al. Elevation of pulmonary CD163+ and CD204+ macrophages is associated with the clinical course of idiopathic pulmonary fibrosis patients[J]. J Thorac Dis, 2019, 11(9):4005-4017. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||
|